Explore 3 Stock Ideas & Industry Insights Download Free Report

Business Overview
Serabi Gold Plc (SRB) is a London-headquartered mining company which is focused on production and exploration of gold in Brazil.
Recent News
On 26th March 2020, the company announced that it had intended to issue its FY2019 annual results for the three months and twelve months periods to 31st December 2019 on or before 30th March 2020. However, due to the global Coronavirus (Covid-19) pandemic, securities regulatory authorities in Canada had granted exemptions allowing companies an additional 45 days to complete their regulatory filings. The company would seek this additional time to assess the longer-term impacts of the economic and other uncertainties created by the global Coronavirus (Covid-19) pandemic. The company is expected to report its annual results for the fiscal year 2019 before 14th April 2020.
Financial Highlights and Operational Highlights
2019 was a year when Serabi Gold Plc attained new milestones on the operational front, and the company would anticipate this to translate into outstanding financial results for the year. In the year, it produced gold of 40,101 ounces from its Palito Mining Complex, which show good performance. The company’s reported revenue for the nine months period ending on 30th September 2019 stood at $43,940 thousand against revenue of $43,262 thousand for the financial year 2018. On 31st December 2019, the company surged its cash to US$14.3 million, representing another quarter of decent financial performance. The company’s EBITDA for the nine months to 30th September 2019 stood at US$12.1 million, which is increased by 120 per cent as compared with the corresponding period in 2018. The net cash flow was US$4.5 million in the nine months to September 30th, 2019.
Share Price Performance

Daily Chart as on 27th March 2020, before the market closed (Source: Thomson Reuters)
On March 27, 2020, at the time of writing (before the market close, at 8:01 AM GMT), Serabi Gold Plc were trading at GBX 51, down by 2.86 per cent against the previous day closing price. Stock’s 52 weeks High and Low are GBX 97/GBX 24.
Conclusion
Due to recent Coronavirus outbreak, the company’s performance has impacted. The outlook in the near term looks bleak, and the Group’s operations are hampering due to this uncertainty. The extent of the impact of COVID-19 uncertainty is unclear as of now, and it would take some time to determine it. In the near-term, the margin expansion and production growth stood at 100,000 oz. The company has a strong platform for EBITDA growth. The medium-term growth from Coringa Project, with permitting process well advanced with construction planned to be underway in Q1 2021 and expected to be in production ramp-up by end 2021. The company had shown good financial performance in the first nine months of 2019 and will also deliver good results for the financial year 2019. The company’s top-line performance has improved, but its bottom-line performance improved significantly. The company has improved its production guidance for the financial year 2019 as against 2018 production.
Based on the decent prospects, we have given a “Speculative Buy” recommendation at the current price of GBX 45.00 (as on 27th March 2020, before the market close at 9:17 AM GMT).
Disclaimer
PLEASE BE ADVISED THAT YOUR CONTINUED USE OF THIS SITE OR THE INFORMATION PROVIDED HEREIN SHALL INDICATE YOUR CONSENT AND AGREEMENT TO THESE TERMS.
References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.
This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332.
The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine is not responsible for material posted on this website and does not guarantee the content, accuracy, or use of the content in this site. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated.
Kalkine do not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not in any way endorse or recommend individuals, products or services that may be discussed on this site. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional licensed financial planner and adviser.
Past performance is not a reliable indicator of future performance.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…